|
Market Cap (6-Jul) $758,238,016 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (19-Jun) 895,750 (0.15%) (396th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 27 May 2022, 11:43. The announcement is not marked as price sensitive, and is 2 page(s) in length and 191.43kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.001% short sold according to ASIC data. It was ranked the 701st most shorted stock on the ASX. It is now ranked as the 396th most shorted stock on the ASX with 0.154% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| PYC Q2 Investor Call - 31 May 2022 | 27 May 2022, 11:43 |
| PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS | 10 May 2022, 8:37 |
| Appendix A Terms and Conditions of Options | 4 May 2022, 15:11 |
| Notification regarding unquoted securities - PYC | 4 May 2022, 15:10 |
You must be logged in to post a reply.
